These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20717006)

  • 41. Intravenous streptokinase in an infant with Kawasaki's disease complicated by acute myocardial infarction.
    Burtt DM; Pollack P; Bianco JA
    Pediatr Cardiol; 1986; 6(6):307-11. PubMed ID: 3748836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease.
    Niwa K; Aotsuka H; Hamada H; Uchishiba M; Terai M; Niimi H
    Coron Artery Dis; 1995 Nov; 6(11):857-64. PubMed ID: 8696530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kawasaki disease: an update.
    Singh GK
    Indian J Pediatr; 1998; 65(2):231-41. PubMed ID: 10771968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A review of Kawasaki disease, a perspective from the articles published in Mexico since January 1977 to May 2012].
    Sotelo-Cruz N
    Arch Cardiol Mex; 2013; 83(3):214-22. PubMed ID: 23663892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kawasaki disease and cardiac involvement: an update on the state of the art.
    Conti G; Giannitto N; De Luca FL; Salpietro A; Oreto L; Viola I; Ceravolo A; Nicocia G; Sio A; Romeo M; Ceravolo G; Cuppari C; Calabrò MP; Chimenz R
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):47-53. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and distribution of atrial natriuretic polypeptide in the ventricles of children with myocarditis and/or myocardial infarction secondary to Kawasaki disease: immunohistochemical study.
    Fujiwara T; Fujiwara H; Takemura G; Mukoyama M; Saito Y; Nakao K; Imura H; Nakano M; Baba K
    Am Heart J; 1990 Sep; 120(3):612-8. PubMed ID: 2143884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Kawasaki disease].
    Castro PA; Urbano LM; Costa IM
    An Bras Dermatol; 2009; 84(4):317-29. PubMed ID: 19851663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular involvement in Kawasaki syndrome.
    Chabali R; Haynes RE
    South Med J; 1983 Mar; 76(3):359-66. PubMed ID: 6131542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Kawasaki disease: interdisciplinary and intersocieties consensus (clinical guidelines). Brief version].
    ;
    Arch Argent Pediatr; 2016 Aug; 114(4):385-90. PubMed ID: 27399018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kawasaki disease: insights into pathogenesis and approaches to treatment.
    Shulman ST; Rowley AH
    Nat Rev Rheumatol; 2015 Aug; 11(8):475-82. PubMed ID: 25907703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kawasaki disease complicated by acute myocardial infarction 9 years after onset.
    Ohyagi A; Hirose K; Tsujimoto S; Doyama K; Watanabe Y; Nakai T
    Am Heart J; 1985 Sep; 110(3):670-2. PubMed ID: 4036795
    [No Abstract]   [Full Text] [Related]  

  • 52. Association of Familial History of Diabetes, Hypertension, Dyslipidemia, Stroke, or Myocardial Infarction With Risk of Kawasaki Disease.
    Kwak JH; Ha EK; Kim JH; Cha HR; Lee SW; Han MY
    J Am Heart Assoc; 2022 Jun; 11(12):e023840. PubMed ID: 35699188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kawasaki Disease.
    Newburger JW
    Curr Treat Options Cardiovasc Med; 2000 Jun; 2(3):227-236. PubMed ID: 11096528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retropharyngeal cellulitis: a manifestation of Kawasaki disease in children.
    Hester TO; Harris JP; Kenny JF; Albernaz MS
    Otolaryngol Head Neck Surg; 1993 Dec; 109(6):1030-3. PubMed ID: 8265186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of acute myocardial dysfunction with disturbed consciousness due to Kawasaki disease.
    Tsuda E; Uchiyama T; Abe T
    Pediatr Int; 2012 Jun; 54(3):e10-4. PubMed ID: 22631582
    [No Abstract]   [Full Text] [Related]  

  • 56. Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.
    Saneeymehri S; Baker K; So TY
    J Pediatr Pharmacol Ther; 2015; 20(3):163-77. PubMed ID: 26170768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insights Into Coronary Artery Lesions in Kawasaki Disease.
    Zhang D; Liu L; Huang X; Tian J
    Front Pediatr; 2020; 8():493. PubMed ID: 32984207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication analysis and pharmaceutical care for a child with Kawasaki disease: A case report and review of the literature.
    Lai Y; Feng M; Deng J; Tan B; Ban J; Zheng J
    Medicine (Baltimore); 2023 Jan; 102(1):e32488. PubMed ID: 36607867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can Breastfeeding in Early Life Protect Infants and Children from Kawasaki Disease, Neonatologists Viewpoint.
    Jain A
    Indian Pediatr; 2016 Aug; 53(8):725-6. PubMed ID: 27567649
    [No Abstract]   [Full Text] [Related]  

  • 60. Management of acute myocardial infarction.
    Glass M
    S Afr Med J; 1971 Oct; 45(38):1072. PubMed ID: 5122092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.